What is Eyedaptic?
Eyedaptic specializes in the development of sophisticated smart glasses engineered specifically for individuals diagnosed with Age-Related Macular Degeneration (AMD) and various other central vision impairments. At the core of its product suite is patented software that utilizes augmented reality to optimize peripheral vision, thereby facilitating greater independence for users during daily activities. Furthermore, the integration of IVY, a Generative AI Visual Assistant, represents a strategic evolution in their product roadmap, providing real-time visual interpretation for those with limited sight. With a target demographic exceeding 250 million individuals globally, Eyedaptic is transforming the landscape of retinal disease management through scalable, high-tech interventions.
How much funding has Eyedaptic raised?
Eyedaptic has raised a total of $30K across 1 funding round:
Debt
$30K
Debt (2021): $30K with participation from PPP
Key Investors in Eyedaptic
PPP
Public-Private Partnership
What's next for Eyedaptic?
Following this significant Series B/C stage financing, Eyedaptic is well-positioned to accelerate its commercial scaling and research initiatives. The company is expected to prioritize the expansion of its distribution channels and the refinement of its AI-driven visual assistance capabilities. As the firm matures, the focus will likely shift toward deepening clinical partnerships and enhancing the accessibility of its hardware, ensuring that its technological advancements reach a broader patient base. This capital infusion provides the necessary runway to solidify its market presence and continue its trajectory of innovation in the specialized eyewear market.
See full Eyedaptic company page
